Awaiting development: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Type |
|---|---|
| Tozorakimab for treating exacerbations of chronic obstructive pulmonary disease after optimised inhaled dual or triple therapy [ID6711] | Technology appraisal guidance |
| Title | Type |
|---|---|
| Tozorakimab for treating exacerbations of chronic obstructive pulmonary disease after optimised inhaled dual or triple therapy [ID6711] | Technology appraisal guidance |